Drugmakers seek clarity from FDA on manufacturing interruption notifications
Back in April, the FDA published draft guidance on when and how a pharma company can notify the agency of an interruption or halt to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
